SB

Sireesha Bura

Active Director Director DIN 09633398
DIN 09633398 First appointment May 2022 Primary industry Home Appliances
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value •••• Premium profile

About Sireesha Bura

Data last updated:

Sireesha Bura is a Director at Galton Pharmaceuticals Private Limited (since 2022). The company operates in Home Appliances. Galton Pharmaceuticals Private Limited reported revenue of ₹1.28 Cr (FY 2025).

DIN 09633398
Primary Designation Director
Industry Home Appliances
First Appointment 26 May 2022
Oldest Company Age 7 yrs
Largest company Galton Pharmaceuticals Private Limited · ₹1.28 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 May 20222018₹1.28 Cr (FY 2025)Active

Board colleagues of Sireesha Bura

Directorship timeline

Open interactive timeline →
Galton Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sireesha Bura

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sireesha Bura

Sireesha Bura currently holds 1 directorship: Galton Pharmaceuticals Private Limited (Director, since 26 May 2022, revenue ₹1.28 Cr (FY 2025)).

Sireesha Bura was first appointed on 26 May 2022 as Director at Galton Pharmaceuticals Private Limited.

The current boards of Sireesha Bura's companies include Sravanthi Mukkala (Galton Pharmaceuticals Private Limited), Valdasu Saidulu (Galton Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available